CVE-2026-21980: Oracle Life Sciences Central Coding · Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to
Affects Oracle Life Sciences Central CodingSource CVE Database V5
Not known to be exploited · CVSS 6.5 Medium.
Data as of 26 Oct 2026, 07:57 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 12% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 20 Jan 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2026-10-26.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Oracle CorporationOracle Life Sciences Central Coding | Affected
| Fixed in– |
Mavencom.oracle/Oracle-Life-Sciences-Central-Codingpkg:maven/com.oracle/Oracle-Life-Sciences-Central-CodingOther threats | Affected
| Fixed in– |
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
1. Apply official Oracle patches or updates for version 7.0.1.0 as soon as they become available to remediate the vulnerability. 2. Restrict network access to Oracle Life Sciences Central Coding servers by implementing strict firewall rules and network segmentation, limiting HTTP access to trusted internal systems only. 3. Employ web application firewalls (WAF) to detect and block suspicious HTTP requests targeting the vulnerable endpoints. 4. Monitor logs and audit trails for unusual data access patterns, unauthorized data modifications, or unexpected HTTP requests to the affected application. 5. Conduct regular security assessments and penetration testing focused on Oracle Health Sciences applications to identify and remediate similar weaknesses. 6. Enforce strong access control policies and multi-factor authentication on administrative interfaces to reduce the risk of lateral movement if the vulnerability is exploited. 7. Educate IT and security teams about the vulnerability and ensure incident response plans include scenarios involving Oracle Life Sciences Central Coding compromise.
Description
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).